Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Risk factors

Topic: Drug trials: efficacy and safety

The German psychiatrist Emil Kraepelin (1856 - 1926) is justly called father of modern psychiatry. He was the first to identify dementia praecox (schizophrenia) and manic-depression, and he pioneered the use of drugs to treat mental illness. He was also joint discoverer of Alzheimer's disease - which he named after his collaborator, Dr Alois Alzheimer. Kraepelin presented these and other discoveries in successive editions of his Psychiatrie: Ein Lehrbuch (definitive 8th edition also now available from Thoemmes Press). Much of this gigantic textbook can only be read in the original German; but parts of it were translated into English, and they had a very profound influence on the development of world psychiatry for the rest of the 20th century. Although Bleuler's name for the disease came to replace Kraepelin's term, Kraepelin's general description of the syndrome and division of it into subforms such as hebephrenia and catatonia has persisted. He succeeded in tying together into a single recognizable diagnostic category a disparate array of symptoms that, before Kraepelin, had not been seen as cohering. Despite myriad later refinements, Kraepelin's description of the syndrome is still the classic presentation; it very much lives on in the Diagnostic and Statistical Manual used by present-day psychiatrists. Dementia Praecox and Paraphrenia (1919) was the book in which Kraepelin first presented his work on schizophrenia to the English-speaking world. It was probably the most influential psychiatric text of the entire 20th century, and has now become rare. Thoemmes Press is pleased to make this facsimile of the first edition available as a single volume.

Key findings

Study details

How this study scored 38/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record left out, no data; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 22 of the 58 points it could be judged on, which is 38 of 100. Total 38 of 100.22 of the 58 points we could judge = 38 of 100

Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 22 of the 58 points we could judge it on, which is 38 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Annals of Internal Medicine)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 1972 — older than 20 years, still counted
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 22 / 58 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 22 of the 58 points we could judge it on is 38 out of 100.
Total 38 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. This record has no authors, so the citation leaves them out. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Dementia Praecox and Paraphrenia. (1972). Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-76-6-1058_8

Vancouver

Dementia Praecox and Paraphrenia. Annals of Internal Medicine. 1972. doi:10.7326/0003-4819-76-6-1058_8.

BibTeX

@article{study1972-10bc1180,
  title   = {{Dementia Praecox and Paraphrenia}},
  journal = {Annals of Internal Medicine},
  year    = {1972},
  doi     = {10.7326/0003-4819-76-6-1058_8},
  url     = {https://doi.org/10.7326/0003-4819-76-6-1058_8}
}

Related studies in Risk factors

Also tagged “late-life-depression”

139 studies in the library carry the topic tag “late-life-depression”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 139 tagged studies.

Similar studies

More on Risk factors

See all studies in Risk factors →